(Q42616157)

3 November 2017

title

Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients (English)

1 reference

3 November 2017

1 reference

1 reference

2

1 reference

3 November 2017

C Cursaro

4

0 references

author name string

A Gramenzi

1

1 reference

3 November 2017

L Micco

3

1 reference

3 November 2017

S Fiorino

5

1 reference

3 November 2017

S Galli

6

1 reference

3 November 2017

S Gitto

7

1 reference

3 November 2017

C Galli

8

1 reference

3 November 2017

G Furlini

9

1 reference

3 November 2017

M Bernardi

10

1 reference

3 November 2017

P Andreone

11

1 reference

3 November 2017

publication date

1 June 2011

1 reference

Journal of Viral Hepatitis

3 November 2017

published in

1 reference

3 November 2017

volume

18

1 reference

3 November 2017

issue

10

1 reference

3 November 2017

page(s)

e468-74

1 reference

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Endpoints of therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Current treatment of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Monitoring during and after antiviral therapy for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Hepatitis B: reflections on the current approach to antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Chronic hepatitis B: back to the future with HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01473.X

10.1111/J.1365-2893.2011.01473.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference